Announcement • Mar 31
Canmax Technologies Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Canmax Technologies Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Announcement • Mar 19
Canmax Technologies Co., Ltd., Annual General Meeting, Apr 09, 2026 Canmax Technologies Co., Ltd., Annual General Meeting, Apr 09, 2026, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu China Announcement • Dec 31
Canmax Technologies Co., Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026 Canmax Technologies Co., Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026 Announcement • Sep 30
Canmax Technologies Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Canmax Technologies Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 Announcement • Jul 02
Canmax Technologies Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Canmax Technologies Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 Announcement • Apr 25
Canmax Technologies Co., Ltd., Annual General Meeting, May 15, 2025 Canmax Technologies Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu China Announcement • Mar 31
Canmax Technologies Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Canmax Technologies Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Announcement • Dec 31
Canmax Technologies Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Canmax Technologies Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to CN¥30.72, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years. New Risk • Oct 30
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 123% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 110% Cash payout ratio: 140% Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin). Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.53 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.53 in 3Q 2023). Revenue: CN¥1.74b (down 23% from 3Q 2023). Net income: CN¥88.4m (down 80% from 3Q 2023). Profit margin: 5.1% (down from 20% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥23.56, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 71% over the past three years. Announcement • Sep 30
Canmax Technologies Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Canmax Technologies Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to CN¥20.57, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 73% over the past three years. Reported Earnings • Aug 07
First half 2024 earnings released: EPS: CN¥1.00 (vs CN¥1.65 in 1H 2023) First half 2024 results: EPS: CN¥1.00 (down from CN¥1.65 in 1H 2023). Revenue: CN¥3.71b (down 44% from 1H 2023). Net income: CN¥834.9m (down 39% from 1H 2023). Profit margin: 23% (up from 21% in 1H 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Jul 01
Now 25% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to CN¥17.36. The fair value is estimated to be CN¥23.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 62% over the last 3 years. Earnings per share has grown by 52%. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period. Announcement • Jun 29
Canmax Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 07, 2024 Canmax Technologies Co., Ltd. announced that they will report first half, 2024 results on Aug 07, 2024 Buy Or Sell Opportunity • Jun 19
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 15% to CN¥18.59. The fair value is estimated to be CN¥23.40, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 62% over the last 3 years. Earnings per share has grown by 52%. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period. Announcement • Apr 24
Canmax Technologies Co., Ltd., Annual General Meeting, May 16, 2024 Canmax Technologies Co., Ltd., Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu China Reported Earnings • Apr 24
Full year 2023 earnings released: EPS: CN¥1.99 (vs CN¥8.63 in FY 2022) Full year 2023 results: EPS: CN¥1.99 (down from CN¥8.63 in FY 2022). Revenue: CN¥10.5b (down 39% from FY 2022). Net income: CN¥1.66b (down 75% from FY 2022). Profit margin: 16% (down from 39% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Apr 20
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 22% to CN¥19.12. The fair value is estimated to be CN¥24.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to decline by 2.4% in 2 years. Earnings are forecast to decline by 55% in the next 2 years. Announcement • Mar 30
Canmax Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024 Canmax Technologies Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 Buy Or Sell Opportunity • Mar 27
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 23% to CN¥19.56. The fair value is estimated to be CN¥24.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to decline by 2.4% in 2 years. Earnings are forecast to decline by 55% in the next 2 years. New Risk • Mar 15
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 29% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 29% per year for the foreseeable future. High level of non-cash earnings (29% accrual ratio). Minor Risks Dividend is not well covered by cash flows (136% cash payout ratio). Profit margins are more than 30% lower than last year (24% net profit margin). New Risk • Feb 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Dividend is not well covered by cash flows (136% cash payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (24% net profit margin). Buy Or Sell Opportunity • Feb 02
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 31% to CN¥18.19. The fair value is estimated to be CN¥23.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥19.03, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 5.0% over the past three years. Announcement • Dec 29
Canmax Technologies Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 Canmax Technologies Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 Announcement • Nov 11
Canmax Technologies Co., Ltd. (SZSE:300390) announces an Equity Buyback for CNY 250 million worth of its shares. Canmax Technologies Co., Ltd. (SZSE:300390) announces a share repurchase program. Under the program, the company will repurchase CNY 250 million worth of its shares. The shares will be repurchased at a price of not more than CNY 39.5 per share. The shares purchased will be used for ESOP and equity incentives. The program is valid for 12 months. Reported Earnings • Oct 24
Third quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥2.15 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.53 (down from CN¥2.15 in 3Q 2022). Revenue: CN¥2.27b (down 53% from 3Q 2022). Net income: CN¥447.1m (down 73% from 3Q 2022). Profit margin: 20% (down from 34% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: CN¥0.59 (vs CN¥2.61 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.59 (down from CN¥2.61 in 2Q 2022). Revenue: CN¥3.10b (down 29% from 2Q 2022). Net income: CN¥493.1m (down 75% from 2Q 2022). Profit margin: 16% (down from 45% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Upcoming Dividend • Apr 28
Upcoming dividend of CN¥2.00 per share at 4.1% yield Eligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 4.1%. Within top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.9%). Reported Earnings • Mar 30
Full year 2022 earnings released: EPS: CN¥11.22 (vs CN¥1.59 in FY 2021) Full year 2022 results: EPS: CN¥11.22 (up from CN¥1.59 in FY 2021). Revenue: CN¥17.0b (up 401% from FY 2021). Net income: CN¥6.59b (up CN¥5.68b from FY 2021). Profit margin: 39% (up from 27% in FY 2021). The increase in margin was driven by higher revenue. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: CN¥2.79 (vs CN¥0.41 in 3Q 2021) Third quarter 2022 results: EPS: CN¥2.79 (up from CN¥0.41 in 3Q 2021). Revenue: CN¥4.80b (up 439% from 3Q 2021). Net income: CN¥1.64b (up CN¥1.41b from 3Q 2021). Profit margin: 34% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • Aug 27
Second quarter 2022 earnings released: EPS: CN¥3.40 (vs CN¥0.29 in 2Q 2021) Second quarter 2022 results: EPS: CN¥3.40 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥4.39b (up 475% from 2Q 2021). Net income: CN¥1.99b (up CN¥1.83b from 2Q 2021). Profit margin: 45% (up from 22% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 41%, compared to a 39% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥96.49, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 96% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥59.44 per share. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥69.91, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 54% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.47 per share. Reported Earnings • Apr 30
First quarter 2022 earnings released: EPS: CN¥2.60 (vs CN¥0.27 in 1Q 2021) First quarter 2022 results: EPS: CN¥2.60 (up from CN¥0.27 in 1Q 2021). Revenue: CN¥3.39b (up 407% from 1Q 2021). Net income: CN¥1.52b (up CN¥1.37b from 1Q 2021). Profit margin: 45% (up from 22% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 100%, compared to a 43% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Mar 05
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥73.59, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Luxury industry in China. Total returns to shareholders of 170% over the past year. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥77.00, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Luxury industry in China. Total returns to shareholders of 177% over the past year. Reported Earnings • Feb 09
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: EPS: CN¥1.59 (up from CN¥0.52 in FY 2020). Revenue: CN¥3.40b (up 159% from FY 2020). Net income: CN¥910.7m (up 218% from FY 2020). Profit margin: 27% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 96%, compared to a 32% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥73.98, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 16x in the Luxury industry in China. Total returns to shareholders of 177% over the past year. Reported Earnings • Oct 14
Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.08 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥890.7m (up 195% from 3Q 2020). Net income: CN¥237.7m (up 465% from 3Q 2020). Profit margin: 27% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue. Reported Earnings • Aug 01
Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.24 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥763.4m (up 44% from 2Q 2020). Net income: CN¥166.5m (up 19% from 2Q 2020). Profit margin: 22% (down from 26% in 2Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • May 29
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥34.67, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 19x in the Luxury industry in China. Reported Earnings • Apr 21
First quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.09 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥668.0m (up 188% from 1Q 2020). Net income: CN¥146.1m (up 208% from 1Q 2020). Profit margin: 22% (up from 21% in 1Q 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥32.26, the stock trades at a forward P/E ratio of 69x. Average forward P/E is 18x in the Luxury industry in China. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥28.95, the stock is trading at a trailing P/E ratio of 66.5x, up from the previous P/E ratio of 57.4x. This compares to an average P/E of 26x in the Luxury industry in China. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improved over the past week After last week's 27% share price gain to CN¥31.16, the stock is trading at a trailing P/E ratio of 71.6x, up from the previous P/E ratio of 56.2x. This compares to an average P/E of 25x in the Luxury industry in China. Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥22.28, the stock is trading at a trailing P/E ratio of 51.2x, up from the previous P/E ratio of 42.5x. This compares to an average P/E of 30x in the Luxury industry in China.